Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 9
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Health care providers | Benchmarking and standard setting |
Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells | Boligan KF, Sandhu G, Branch DR | 2022 | Curr Protoc | View Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells | Researchers | Benchmarking and standard setting |
Management of immune‐mediated thrombocytopenia | Gabe C, Arnold D, Smith J, T W | 2022 | Rossi's Principles of Transfusion Medicine | View Management of immune‐mediated thrombocytopenia | Health care providers | Benchmarking and standard setting |
Why We Swab: A library of stories in stem cell donation | Jagelaviciute G, Kum E, Li EW, Rosenfeld A, Williams K, Kandel R, DeGurse N, Park B, Okonofua S, Sano L, Gerofsky M, Sharp A, Hatkar R, Thyagu S, Fingrut WB | 2022 | Transfusion | View Why We Swab: A library of stories in stem cell donation | Health care providers | Ethical, legal & social implications research |
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ | 2022 | Microbiol Spectr | View Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Health care providers | Benchmarking and standard setting |
Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | O’Brien SF, Drews SJ, Lewin A, Osiowy C, Drebot MA, Renaud C | 2022 | Relevé des maladies transmissibles au Canada | View Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | Health care providers | New or improved product or process |
A mixed methods investigation of the relationship between blood donor policy, interest in donation, and willingness to donate among gay, bisexual, and other men who have sex with men in Ontario, Canada | Armstrong JP, Brennan DJ, Collict D, Kesler M, Bekele T, Souleymanov R, Grace D, Lachowsky NJ, Hart TA, Adam BD | 2022 | BMC Public Health | View A mixed methods investigation of the relationship between blood donor policy, interest in donation, and willingness to donate among gay, bisexual, and other men who have sex with men in Ontario, Canada | Researchers | MSM research |
Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men | Castillo G, Vesnaver E, Gibson E, Butler-Foster T, Goldman M, Hill NE, Rosser A, Lapierre D, Rubini KA, MacDonagh R, Miguel G, Palumbo A, MacPherson P, Randall T, Osbourne-Sorrell W, O'Brien SF, Bridel W, Otis J, Greaves M, Al-Bakri TB, Reid M, Labrecque M, Germain M, Orvis S, Clapperton AT, Devine D, Presseau J | 2022 | Transfusion | View Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men | Blood operators | MSM research |
A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic | Grunau B, O’Brien SF, Kirkham TL, Helmer J, Demers PA, Asamoah-Boaheng M, Drews SJ, Karim ME, Srigley JA, Sediqi S, O’Neill D, Drennan IR, Goldfarb DM | 2022 | Ann Emerg Med | View A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic | Researchers | Clinical research |
Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Pavenski K, Khandelwal A, Clarke G, Lane D | 2022 | National Advisory Committee on Blood and Blood Products | View Déclaration du CCN concernant le génotypage du RHD chez les patientes enceintes | Health care providers | Benchmarking and standard setting |
T cell-mediated autoimmunity in immune thrombocytopenia | Vrbensky JR, Nazy I, Clare R, Larché M, Arnold DM | 2022 | Eur J Haematol | View T cell-mediated autoimmunity in immune thrombocytopenia | Researchers | Clinical research |
Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost | Obaidallah N, Downie H, Colavecchia C, Callum J, Lin Y | 2022 | Transfusion | View Implementation of a blood bank generated tube for second blood group determination: Challenges, yield, and cost | Health care providers | New or improved product or process |
Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a <em>post hoc</em> analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial | Bartoszko J, Martinez-Perez S, Callum J, Karkouti K, Farouh ME, Scales DC, Heddle NM, Crowther M, Rao V, Hucke H-P, Carroll J, Grewal D, Brar S, Brussières J, Grocott H, Harle C, Pavenski K, Rochon A, Saha T, Shepherd L, Syed S, Tran D, Wong D, Zeller M | 2022 | Br J Anaesth | View Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a <em>post hoc</em> analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial | Researchers | Clinical research |
Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel | Dibernardo A, Toledo NP, Robinson A, Osiowy C, Giles E, Day J, Lindsay LR, Drebot MA, Booth TF, Pidduck T, Baily A, Charlton CL, Tipples G, Kanji JN, Brochu G, Lang A, Therrien C, Bélanger-Collard M, Beaulac S-N, Gilfix BM, Boivin G, Hamelin M-È, Carbonneau J, Lévesque S, Martin P, Finzi A, Gendron-Lepage G, Goyette G, Benlarbi M, Gasser R, Fortin C, Martel-Lafferrière V, Lavoie M, Guérin R, Haraoui L-P, Renaud C, Jenkins C, O'Brien SF, Drews SJ, Conrod V, Tran V, Awrey B, Scheuermann R, DuPuis A, Payne A, Warszycki C, Girardin R, Lee W, Zahariadis G, Jiao L, Needle R, Cordenbach J, Zaharatos J, Taylor K, Teltscher M, Miller M, Elsherif M, Robertson P, Robinson JL | 2022 | J Assoc Med Microbiol Infect Dis Can | View Evaluation of the performance of multiple immunoassay diagnostic platforms on the National Microbiology Laboratory SARS-CoV-2 National Serology Panel | Researchers | Benchmarking and standard setting |
The bending rigidity of the red blood cell cytoplasmic membrane | Himbert S, D’Alessandro A, Qadri SM, Majcher MJ, Hoare T, Sheffield WP, Nagao M, Nagle JF, Rheinstädter MC | 2022 | PLoS One | View The bending rigidity of the red blood cell cytoplasmic membrane | Researchers | Basic research |
FAQ: Information for health professionals on pathogen-reduced platelets | Ning S, Tordon B, Zeller M, Anani W | 2022 | Blood.ca website | View FAQ: Information for health professionals on pathogen-reduced platelets | Health care providers | New or improved product or process |
Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study | Quee F, O'Brien SF, Prinsze F, Steele WR, Grégoire Y, Cutajar A, Wendel S, Compernolle V, Goldman M, van den Hurk K, Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Vox Sang | View Whole blood donor return rates after deferral for tattooing or body piercing—Survey across blood donation services: The BEST collaborative study | Blood operators | Benchmarking and standard setting |
Sommaire des réactions transfusionnelles indésirables | Yan M | 2022 | Blood.ca website | View Sommaire des réactions transfusionnelles indésirables | Blood operators | Benchmarking and standard setting |
Pathogen-reduced buffy coat platelets | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Pathogen-reduced buffy coat platelets | Health care providers | Benchmarking and standard setting |
Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility | Al-Riyami AZ, Estcourt L, Rahimi-Levene N, Bloch EM, Goel R, Tiberghien P, Thibert J-B, Bruun MT, Devine DV, Gammon RR, Wendel S, Toungouz Nevessignsky M, Grubovic Rastvorceva RM, Oreh A, Romon I, van den Berg K, Kitazawa J, Patidar G, So-Osman C, Wood EM, the ISBT COVID-19 Convalescent Plasma Working Group | 2022 | Vox Sang | View Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility | Health care providers | Clinical research |
von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells | Bowman M, Casey L, Selvam SN, Lima PDA, Rawley O, Hinds M, Tuttle A, Grabell J, Iorio A, Walker I, Lillicrap D, James P | 2022 | J Thromb Haemost | View von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells | Researchers | Basic research |
Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Jevtic SD, Arnold DM, Modi D, Ivetic N, Bissola AL, Nazy I | 2022 | Front Cardiovasc Med | View Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis | Health care providers | Clinical research |
Accuracy of International Classification of Diseases, 10th Revision Codes for Identifying Sepsis: A Systematic Review and Meta-Analysis | Liu B, Hadzi-Tosev M, Liu Y, Lucier KJ, Garg A, Li S, Heddle NM, Rochwerg B, Ning S | 2022 | Crit Care Explor | View Accuracy of International Classification of Diseases, 10th Revision Codes for Identifying Sepsis: A Systematic Review and Meta-Analysis | Health care providers | Clinical research |
A Primer on Biostatistics | Shih AW, Li N, Montemayor C, Heddle NM | 2022 | Practical Transfusion Medicine | View A Primer on Biostatistics | Health care providers | Benchmarking and standard setting |
Concentré de recherche: Des questions de sélection fondées sur le comportement sexuel?: comprendre et atténuer le?malaise des donneurs | Woo H | 2022 | Blood.ca website | View Concentré de recherche: Des questions de sélection fondées sur le comportement sexuel?: comprendre et atténuer le?malaise des donneurs | Blood operators | MSM research |
User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study | Germini F, Borg Debono V, Page D, Zuk V, Kucher A, Cotoi C, Hobson N, Sevestre M, Skinner MW, Iorio A | 2022 | JMIR Hum Factors | View User-Centered Development and Testing of the Online Patient-Reported Outcomes, Burdens, and Experiences (PROBE) Survey and the myPROBE App and Integration With the Canadian Bleeding Disorder Registry: Mixed Methods Study | Researchers | Benchmarking and standard setting |
Heparin or nonheparin anticoagulants for VITT | Arnold DM | 2022 | Blood | View Heparin or nonheparin anticoagulants for VITT | Health care providers | Clinical research |
A personalized limited sampling approach to better estimate terminal half-life of FVIII concentrates | Chelle P, Iorio A, Edginton AN | 2022 | J Thromb Haemost | View A personalized limited sampling approach to better estimate terminal half-life of FVIII concentrates | Researchers | Basic research |
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals | Grunau B, Prusinkiewicz M, Asamoah-Boaheng M, Golding L, Lavoie PM, Petric M, Levett PN, Haig S, Barakauskas V, Karim ME, Jassem AN, Drews SJ, Sediqi S, Goldfarb DM | 2022 | Microbiol Spectr | View Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals | Researchers | Clinical research |
Use of Irradiated Red Blood Cell Transfusions in Newborns to Improve Intracerebral Saturation | Kirpalani HM, Prokopchuk-Gauk O, Heddle NM | 2022 | JAMA Pediatr | View Use of Irradiated Red Blood Cell Transfusions in Newborns to Improve Intracerebral Saturation | Health care providers | New or improved product or process |
Freeze-dried plasma: From damage control resuscitation to coronavirus disease 2019 therapy | Peng HT, Rhind SG, Moes K, Devine D, Jenkins C, Beckett A | 2022 | Transfusion | View Freeze-dried plasma: From damage control resuscitation to coronavirus disease 2019 therapy | Health care providers | New or improved product or process |
Frequency and utility of bone marrow examination in relapsed/refractory immune thrombocytopenia | Taparia K, Wall E, Arnold DM, Sun HL | 2022 | J Thromb Haemost | View Frequency and utility of bone marrow examination in relapsed/refractory immune thrombocytopenia | Researchers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia | Klok FA, Pai M, Huisman MV, Makris M | 2022 | Lancet Haematol | View Vaccine-induced immune thrombotic thrombocytopenia | Researchers | Clinical research |
Immunohematology testing using umbilical cord blood: review of the literature, survey of practice and guidance development | Hajjaj OI, Clarke G, Lieberman L, Canadian Obstetrical Pediatric Transfusion Network | 2022 | Transfusion | View Immunohematology testing using umbilical cord blood: review of the literature, survey of practice and guidance development | Health care providers | Benchmarking and standard setting |
The recipe for TACO: A narrative review on the pathophysiology and potential mitigation strategies of transfusion-associated circulatory overload | Bulle EB, Klanderman RB, Pendergrast J, Cserti-Gazdewich C, Callum J, Vlaar APJ | 2022 | Blood Rev | View The recipe for TACO: A narrative review on the pathophysiology and potential mitigation strategies of transfusion-associated circulatory overload | Health care providers | Clinical research |
Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression | Bhullar KS, Nael MA, Elokely KM, Drews SJ, Wu J | 2022 | Pharmaceutics | View Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression | Researchers | Basic research |
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case-control study in Canada | Ding Z, Sherlock M, Chan AKC, Zachos M | 2022 | Blood Coagul Fibrinolysis | View Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case-control study in Canada | Researchers | Clinical research |
Assessing unintentional creation of bias against men who have sex with men as a function of exposure to blood donor screening questionnaire: A national randomized controlled trial | Hofkirchner A, Kohut T, O'Brien SF, Fisher WA | 2022 | Transfusion | View Assessing unintentional creation of bias against men who have sex with men as a function of exposure to blood donor screening questionnaire: A national randomized controlled trial | Researchers | MSM research |
Research partnerships between blood services and public health authorities: An international, cross-sectional survey | Lewin A, Osiowy C, Erikstrup C, Custer B, Renaud C, Tiberghien P, Russell A, Lieshout-Krikke R, O'Brien SF, the Surveillance Risk Assessment Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party | 2022 | Vox Sang | View Research partnerships between blood services and public health authorities: An international, cross-sectional survey | Blood operators | Benchmarking and standard setting |
FAQ : Information destinée aux professionnels de la santé concernant les plaquettes à teneur réduite en agents pathogènes | Ning S, Tordon B, Zeller M, Anani W | 2022 | Blood.ca website | View FAQ : Information destinée aux professionnels de la santé concernant les plaquettes à teneur réduite en agents pathogènes | Health care providers | New or improved product or process |
Tips, tricks, and thoughts on the future of prehospital blood transfusions | Yazer MH, Beckett A, Corley J, Devine DV, Studer NM, Taylor AL, Ward KR, Cap AP | 2022 | Transfusion | View Tips, tricks, and thoughts on the future of prehospital blood transfusions | Health care providers | Clinical research |
Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays | Tuite AR, Fisman D, Abe KT, Rathod B, Pasculescu A, Colwill K, Gingras A-C, Yi Q-L, O’Brien SF, Drews SJ, Pride DT | 2022 | Microbiol Spectr | View Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays | Researchers | Basic research |
Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review | Saeed S, Uzicanin S, Lewin A, Lieshout-Krikke R, Faddy H, Erikstrup C, Osiowy C, Seed CR, Steele WR, Davison K, Custer B, O'Brien SF, Assessment SR, Policy Sub-group of the Transfusion Transmitted Infectious Diseases Working Party of the International Society of Blood Transfusion | 2022 | Vox Sang | View Current challenges of severe acute respiratory syndrome coronavirus 2 seroprevalence studies among blood donors: A scoping review | Researchers | Basic research |
Impact of product platelet count reduction on platelet demand in Canada | Devine DV | 2022 | Transfusion | View Impact of product platelet count reduction on platelet demand in Canada | Blood operators | Benchmarking and standard setting |
Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit | Bhatia K, Solanki S, Paes B, Chan AKC, Bhatt MD | 2022 | Pediatr Blood Cancer | View Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit | Researchers | Clinical research |
Mitapivat versus Placebo for Pyruvate Kinase Deficiency | Al-Samkari H, Galactéros F, Glenthøj A, Rothman JA, Andres O, Grace RF, Morado-Arias M, Layton DM, Onodera K, Verhovsek M, Barcellini W, Chonat S, Judge MP, Zagadailov E, Xu R, Hawkins P, Beynon V, Gheuens S, van Beers EJ | 2022 | N Engl J Med | View Mitapivat versus Placebo for Pyruvate Kinase Deficiency | Researchers | Clinical research |
Chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia | Branch DR, Leger RM, Sakac d, Yi Q, Duong T, Yeung RSM, Binnington B, Bloch EM | 2022 | Blood Adv | View Chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia | Researchers | Basic research |
Directive no 343 réaffirmée : Prédiction du génotype RHD fœtal par test prénatal non invasif de routine | Johnson J-A, MacDonald K, Clarke G, Skoll A | 2022 | J Obstet Gynaecol Can | View Directive no 343 réaffirmée : Prédiction du génotype RHD fœtal par test prénatal non invasif de routine | Health care providers | Benchmarking and standard setting |
Rapid potency assessment of autologous peripheral blood stem cells by intracellular flow cytometry: the PBSC-IL-3-pSTAT5 assay | Simard C, Fournier D, Pineault N, Trépanier P | 2022 | Cytotherapy | View Rapid potency assessment of autologous peripheral blood stem cells by intracellular flow cytometry: the PBSC-IL-3-pSTAT5 assay | Researchers | New or improved product or process |
ResearchUnit: Sexual behaviour-based screening questions: Understanding and mitigating donor discomfort | Woo H | 2022 | Blood.ca website | View ResearchUnit: Sexual behaviour-based screening questions: Understanding and mitigating donor discomfort | Blood operators | MSM research |